Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation.

Stefano BranzoliMassimiliano MariniFabrizio GuarraciniCarlo PederzolliClaudio PomarolliGiovanni D'OnghiaMaurizio CentonzeMauro FantinelFrancesco CorsiniRoberto BonmassariAngelo GraffignaMark La Meir

Published in: Journal of cardiovascular electrophysiology (2020)

Thoracoscopic epicardial closure of the LAA with the AtriClip PRO2 device is a potentially safe and efficient treatment for stroke prevention in patients with NVAF contraindicated for anticoagulant therapy or APT.

Keyphrases

atrial fibrillation
left atrial appendage
catheter ablation
venous thromboembolism
anti inflammatory
mesenchymal stem cells
subarachnoid hemorrhage
brain injury